Fluidigm Corp
Change company Symbol lookup
Select an option...
FLDM Fluidigm Corp
PFE Pfizer Inc
AGNC Agnc Investment Corp
AAPL Apple Inc
GRTYA Guaranty Corp
SATS EchoStar Corp
$DJI Dow Jones Industrials
TIKK Tel-Instrument Electronics Corp
TEAM Atlassian Corporation PLC
PAYX Paychex Inc
Go

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

Price
Delayed
$6.09
Day's Change
0.03 (0.50%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.29
Day's Low
5.99
Volume
(Light)

Today's volume of 863,215 shares is on pace to be much lighter than FLDM's 10-day average volume of 1,954,484 shares.

863,215

CLASS ACTION UPDATE for NXTC, FLDM and BTU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

6:20 am ET October 26, 2020 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / October 26, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

NXTC Shareholders Click Here: https://www.zlk.com/pslra-1/nextcure-inc-information-request-form?prid=10443&wire=1FLDM Shareholders Click Here: https://www.zlk.com/pslra-1/fluidigm-corporation-information-request-form?prid=10443&wire=1BTU Shareholders Click Here: https://www.zlk.com/pslra-1/peabody-energy-corporation-loss-submission-form?prid=10443&wire=1

* ADDITIONAL INFORMATION BELOW *

Nextcure, Inc. (NASDAQ:NXTC)

The Nextcure lawsuit was filed on behalf of investors who purchased Nextcure, Inc. (NASDAQ: NXTC) securities: (1) between November 5, 2019 and July 14, 2020, inclusive; and/or (2) pursuant or traceable to the company's secondary public offering declared effective on November 14, 2019.Lead Plaintiff Deadline : November 20, 2020TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/nextcure-inc-information-request-form?prid=10443&wire=1

Throughout the class period defendants' statements were materially misleading because the data Defendants possessed on its principle product candidate, NC318, showed a lack of efficacy and objective responses. Had the truth been revealed, the market would have seen that NC318 was not, in fact, effective in treating most tumor types, that the NC318 application was proving to be limited (if even useful at all), and, as a result, there was a significant realizable risk that NC318 would not be nearly as popular as then-existing blockbuster drugs, such as Keytruda.

Fluidigm Corporation (NASDAQ:FLDM)

FLDM Lawsuit on behalf of: investors who purchased February 7, 2019 - November 5, 2019Lead Plaintiff Deadline : November 20, 2020TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/fluidigm-corporation-information-request-form?prid=10443&wire=1

According to the filed complaint, during the class period, Fluidigm Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) Fluidigm was experiencing longer sales cycles; (2) as a result, Fluidigm's revenue was reasonably likely to decline; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Peabody Energy Corporation (NYSE:BTU)

BTU Lawsuit on behalf of: investors who purchased April 3, 2017 - October 28, 2019Lead Plaintiff Deadline : November 27, 2020TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/peabody-energy-corporation-loss-submission-form?prid=10443&wire=1

According to the filed complaint, during the class period, Peabody Energy Corporation made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had failed to implement adequate safety controls at the North Goonyella mine to prevent the risk of a spontaneous combustion event; (b) the Company failed to follow its own safety procedures; (c) as a result, the North Goonyella mine was at a heightened risk of shutdown; (d) the Company's low-cost plan to restart operations at the mine posed unreasonable safety and environmental risks; (e) The Australian body responsible for ensuring acceptable health and safety standards, the Queensland Mines Inspectorate, would likely mandate a safer, cost-prohibitive approach; and (f) as a result, there would be major delays in reopening the North Goonyella mine and restarting coal production.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.55 Broadway, 10th FloorNew York, NY 10006jlevi@levikorsinsky.comTel: (212) 363-7500Fax: (212) 363-7171www.zlk.com

SOURCE: Levi & Korsinsky, LLP

View source version on accesswire.com: https://www.accesswire.com/612213/CLASS-ACTION-UPDATE-for-NXTC-FLDM-and-BTU-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.